Drug Screening

Drug Screening

Global Drug Screening Market to Reach $28.2 Billion by 2030
The global market for Drug Screening estimated at US$9.7 Billion in the year 2023, is expected to reach US$28.2 Billion by 2030, growing at a CAGR of 14.4% over the period 2023-2030. Drug Screening Products, one of the segments analyzed in the report, is expected to record 12.1% CAGR and reach US$14.9 Billion by the end of the analysis period. Growth in the Drug Screening Services segment is estimated at 17.4% CAGR for the next 8-year period.

The U.S. Market is Estimated at $3 Billion, While China is Forecast to Grow at 13.8% CAGR
The Drug Screening market in the U.S. is estimated at US$3 Billion in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$4.9 Billion by the year 2030 trailing a CAGR of 13.8% over the analysis period 2023 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 12.5% and 12.3% respectively over the 2023-2030 period. Within Europe, Germany is forecast to grow at approximately 10.6% CAGR.

Introducing Our Exciting New Report Features for 2024
» Full access to influencer engagement stats
» Free access to our digital archives & "MarketGlass" research platform. Our proprietary MarketGlass platform is fully enabled to unlock creativity and market knowledge of domain experts worldwide in a cohesive and collaborative manner. Our state-of-art tools bring world class market perspectives while protecting participants` privacy and identity. Numbers, statistics and market narrative in the report are based on fully curated insights shared by domain experts and influencers in this space.
» Opportunity to engage with interactive questionnaires that come with real-time data simulator tools & bespoke report generation capabilities
» Full client access to peer collaborative and interactive platform for cross-enterprise smart exchange of ideas
» Complimentary report updates for one year
» Competitor coverage with global market shares of major players
» Player market presence analysis (Strong/Active/Niche/Trivial) across multiple geographies
» Access to curated YouTube video transcripts of domain experts/influencer interviews, podcasts, press statements and event keynotes

What to Expect from the Global Economy in 2024
Edgy geopolitics, and economic instability caused by monetary policy tightening and ensuing higher interest rates will create a tumultuous landscape for 2024. Several factors will continue to exert pressure on the path to recovery including hostilities in the Middle East and increasingly common climate disasters. Among the risks, several positives are also taking shape such as growing signs of disinflation and easing of anxiety over stubborn inflation, supply chain normalization and price moderation despite volatility in energy costs. Elections across several G21 jurisdictions, notably in India and the United States, will have potential ramifications for capital flows and investment strategies. While India emerges as a compelling destination in the global investment landscape, U.S, based tech firms will continue to dominate, fueled by a dynamic ecosystem of talent and capital. Tech opportunities in Silicon Valley and beyond remain attractive for investors seeking high-growth prospects supported largely by a resilient albeit slowing domestic economy and conducive regulatory environment. Europe will continue to battle tight monetary policy and recession risks with U.K. having the most challenging outlook and running the greatest risk of recession in 2024. China remains a wild card with hope for growth in the country underpinned by government spending and improvements in consumer spending. The volatile environment will offer both opportunities and challenges for investors and businesses alike. Embracing volatility as a catalyst for growth together with agility and strategic foresight in navigating investment decisions will remain important for survival.

Select Competitors (Total 53 Featured) -
  • Alere, Inc.
  • Alfa Scientific Designs, Inc.
  • Dragerwerk AG & Co. KGaA
  • F. Hoffmann-La Roche AG
  • Laboratory Corporation of America Holdings (LabCorp)
  • Lifeloc Technologies, Inc.
  • Mpd, Inc.
  • Omega Laboratories, Inc.
  • OraSure Technologies, Inc.
  • Premier Biotech, Inc.
  • Psychemedics Corporation
  • Quest Diagnostics, Inc.
  • Shimadzu Corporation
  • Siemens Healthineers
  • Thermo Fisher Scientific, Inc.
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
Drug Screening – Global Key Competitors Percentage Market Share in 2024 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
Global Economic Update
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Growing Prevalence of Substance Abuse Drives Demand for Comprehensive Drug Screening Solutions
Advances in Immunoassay and Mass Spectrometry Propel Growth in Drug Screening Market
Increasing Focus on Workplace Safety and Compliance Strengthens Business Case for Drug Screening
Rising Adoption of Drug Screening in Healthcare and Rehabilitation Centers Expands Market Opportunities
Growing Use of Drug Screening in Law Enforcement and Forensic Toxicology Drives Market Demand
Increasing Investments in Public Health and Safety Initiatives Propel Growth in Drug Screening Market
Technological Innovations in Lab-on-a-Chip and Microfluidics Propel Adoption in Drug Screening Solutions
Growing Applications of Drug Screening in Sports and Athletics Drive Market Expansion
Rising Demand for Home and At-Home Testing Kits Expands Addressable Market for Consumer-Driven Drug Screening
Increasing Use of Drug Screening in Criminal Justice and Corrections Expands Market Opportunities
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Recent Past, Current & Future Analysis for Drug Screening by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 2: World Historic Review for Drug Screening by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 3: World 16-Year Perspective for Drug Screening by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
TABLE 4: World Recent Past, Current & Future Analysis for Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 5: World Historic Review for Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 6: World 16-Year Perspective for Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 7: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 8: World Historic Review for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 9: World 16-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 10: World Recent Past, Current & Future Analysis for Urine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 11: World Historic Review for Urine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 12: World 16-Year Perspective for Urine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 13: World Recent Past, Current & Future Analysis for Breath by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 14: World Historic Review for Breath by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 15: World 16-Year Perspective for Breath by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 16: World Recent Past, Current & Future Analysis for Oral Fluid by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 17: World Historic Review for Oral Fluid by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 18: World 16-Year Perspective for Oral Fluid by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 19: World Recent Past, Current & Future Analysis for Hair by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 20: World Historic Review for Hair by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 21: World 16-Year Perspective for Hair by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 22: World Recent Past, Current & Future Analysis for Other Sample Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 23: World Historic Review for Other Sample Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 24: World 16-Year Perspective for Other Sample Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 25: World Drug Screening Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
III. MARKET ANALYSIS
UNITED STATES
Drug Screening Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
TABLE 26: USA Recent Past, Current & Future Analysis for Drug Screening by Component - Products and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 27: USA Historic Review for Drug Screening by Component - Products and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 28: USA 16-Year Perspective for Drug Screening by Component - Percentage Breakdown of Value Sales for Products and Services for the Years 2014, 2024 & 2030
TABLE 29: USA Recent Past, Current & Future Analysis for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 30: USA Historic Review for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 31: USA 16-Year Perspective for Drug Screening by Sample Type - Percentage Breakdown of Value Sales for Urine, Breath, Oral Fluid, Hair and Other Sample Types for the Years 2014, 2024 & 2030
CANADA
TABLE 32: Canada Recent Past, Current & Future Analysis for Drug Screening by Component - Products and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 33: Canada Historic Review for Drug Screening by Component - Products and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 34: Canada 16-Year Perspective for Drug Screening by Component - Percentage Breakdown of Value Sales for Products and Services for the Years 2014, 2024 & 2030
TABLE 35: Canada Recent Past, Current & Future Analysis for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 36: Canada Historic Review for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 37: Canada 16-Year Perspective for Drug Screening by Sample Type - Percentage Breakdown of Value Sales for Urine, Breath, Oral Fluid, Hair and Other Sample Types for the Years 2014, 2024 & 2030
JAPAN
Drug Screening Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
TABLE 38: Japan Recent Past, Current & Future Analysis for Drug Screening by Component - Products and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 39: Japan Historic Review for Drug Screening by Component - Products and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 40: Japan 16-Year Perspective for Drug Screening by Component - Percentage Breakdown of Value Sales for Products and Services for the Years 2014, 2024 & 2030
TABLE 41: Japan Recent Past, Current & Future Analysis for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 42: Japan Historic Review for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 43: Japan 16-Year Perspective for Drug Screening by Sample Type - Percentage Breakdown of Value Sales for Urine, Breath, Oral Fluid, Hair and Other Sample Types for the Years 2014, 2024 & 2030
CHINA
Drug Screening Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
TABLE 44: China Recent Past, Current & Future Analysis for Drug Screening by Component - Products and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 45: China Historic Review for Drug Screening by Component - Products and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 46: China 16-Year Perspective for Drug Screening by Component - Percentage Breakdown of Value Sales for Products and Services for the Years 2014, 2024 & 2030
TABLE 47: China Recent Past, Current & Future Analysis for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 48: China Historic Review for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 49: China 16-Year Perspective for Drug Screening by Sample Type - Percentage Breakdown of Value Sales for Urine, Breath, Oral Fluid, Hair and Other Sample Types for the Years 2014, 2024 & 2030
EUROPE
Drug Screening Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
TABLE 50: Europe Recent Past, Current & Future Analysis for Drug Screening by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 51: Europe Historic Review for Drug Screening by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 52: Europe 16-Year Perspective for Drug Screening by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
TABLE 53: Europe Recent Past, Current & Future Analysis for Drug Screening by Component - Products and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 54: Europe Historic Review for Drug Screening by Component - Products and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 55: Europe 16-Year Perspective for Drug Screening by Component - Percentage Breakdown of Value Sales for Products and Services for the Years 2014, 2024 & 2030
TABLE 56: Europe Recent Past, Current & Future Analysis for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 57: Europe Historic Review for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 58: Europe 16-Year Perspective for Drug Screening by Sample Type - Percentage Breakdown of Value Sales for Urine, Breath, Oral Fluid, Hair and Other Sample Types for the Years 2014, 2024 & 2030
FRANCE
Drug Screening Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
TABLE 59: France Recent Past, Current & Future Analysis for Drug Screening by Component - Products and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 60: France Historic Review for Drug Screening by Component - Products and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 61: France 16-Year Perspective for Drug Screening by Component - Percentage Breakdown of Value Sales for Products and Services for the Years 2014, 2024 & 2030
TABLE 62: France Recent Past, Current & Future Analysis for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 63: France Historic Review for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 64: France 16-Year Perspective for Drug Screening by Sample Type - Percentage Breakdown of Value Sales for Urine, Breath, Oral Fluid, Hair and Other Sample Types for the Years 2014, 2024 & 2030
GERMANY
Drug Screening Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
TABLE 65: Germany Recent Past, Current & Future Analysis for Drug Screening by Component - Products and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 66: Germany Historic Review for Drug Screening by Component - Products and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 67: Germany 16-Year Perspective for Drug Screening by Component - Percentage Breakdown of Value Sales for Products and Services for the Years 2014, 2024 & 2030
TABLE 68: Germany Recent Past, Current & Future Analysis for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 69: Germany Historic Review for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 70: Germany 16-Year Perspective for Drug Screening by Sample Type - Percentage Breakdown of Value Sales for Urine, Breath, Oral Fluid, Hair and Other Sample Types for the Years 2014, 2024 & 2030
ITALY
TABLE 71: Italy Recent Past, Current & Future Analysis for Drug Screening by Component - Products and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 72: Italy Historic Review for Drug Screening by Component - Products and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 73: Italy 16-Year Perspective for Drug Screening by Component - Percentage Breakdown of Value Sales for Products and Services for the Years 2014, 2024 & 2030
TABLE 74: Italy Recent Past, Current & Future Analysis for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 75: Italy Historic Review for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 76: Italy 16-Year Perspective for Drug Screening by Sample Type - Percentage Breakdown of Value Sales for Urine, Breath, Oral Fluid, Hair and Other Sample Types for the Years 2014, 2024 & 2030
UNITED KINGDOM
Drug Screening Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
TABLE 77: UK Recent Past, Current & Future Analysis for Drug Screening by Component - Products and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 78: UK Historic Review for Drug Screening by Component - Products and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 79: UK 16-Year Perspective for Drug Screening by Component - Percentage Breakdown of Value Sales for Products and Services for the Years 2014, 2024 & 2030
TABLE 80: UK Recent Past, Current & Future Analysis for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 81: UK Historic Review for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 82: UK 16-Year Perspective for Drug Screening by Sample Type - Percentage Breakdown of Value Sales for Urine, Breath, Oral Fluid, Hair and Other Sample Types for the Years 2014, 2024 & 2030
REST OF EUROPE
TABLE 83: Rest of Europe Recent Past, Current & Future Analysis for Drug Screening by Component - Products and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 84: Rest of Europe Historic Review for Drug Screening by Component - Products and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 85: Rest of Europe 16-Year Perspective for Drug Screening by Component - Percentage Breakdown of Value Sales for Products and Services for the Years 2014, 2024 & 2030
TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 87: Rest of Europe Historic Review for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 88: Rest of Europe 16-Year Perspective for Drug Screening by Sample Type - Percentage Breakdown of Value Sales for Urine, Breath, Oral Fluid, Hair and Other Sample Types for the Years 2014, 2024 & 2030
ASIA-PACIFIC
Drug Screening Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
TABLE 89: Asia-Pacific Recent Past, Current & Future Analysis for Drug Screening by Component - Products and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 90: Asia-Pacific Historic Review for Drug Screening by Component - Products and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 91: Asia-Pacific 16-Year Perspective for Drug Screening by Component - Percentage Breakdown of Value Sales for Products and Services for the Years 2014, 2024 & 2030
TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 93: Asia-Pacific Historic Review for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 94: Asia-Pacific 16-Year Perspective for Drug Screening by Sample Type - Percentage Breakdown of Value Sales for Urine, Breath, Oral Fluid, Hair and Other Sample Types for the Years 2014, 2024 & 2030
REST OF WORLD
TABLE 95: Rest of World Recent Past, Current & Future Analysis for Drug Screening by Component - Products and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 96: Rest of World Historic Review for Drug Screening by Component - Products and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 97: Rest of World 16-Year Perspective for Drug Screening by Component - Percentage Breakdown of Value Sales for Products and Services for the Years 2014, 2024 & 2030
TABLE 98: Rest of World Recent Past, Current & Future Analysis for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 99: Rest of World Historic Review for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 100: Rest of World 16-Year Perspective for Drug Screening by Sample Type - Percentage Breakdown of Value Sales for Urine, Breath, Oral Fluid, Hair and Other Sample Types for the Years 2014, 2024 & 2030
IV. COMPETITION

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings